跳至主要内容
临床试验/JPRN-UMIN000013756
JPRN-UMIN000013756已完成未知

A prospective study of the predictive capabilities of 18[F]-FDG-PET in patients with first relapsed/refractory follicular lymphoma following treatment with Bendamustine+Rituximab therapy - W-JHS NHL01 study

Cooperative study between the West Japan Hematology Study Group and Clinical Research Support Center Kyushu0 个研究点目标入组 75 人开始时间: 2014年4月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • •1) Patients who were determined histologic transformation by biopsy in recurrence (not mandatory). 2) Patients with histological grade 3b. 3) Patients with former treatment of radiation therapy or steroid treatment alone. 4) Pregnant or lactating women. Female patients of childbearing potential, or cannot use or not intent to use an appropriate sterilization within 1year under menopause during a treatment period. 5) Patients with active double cancer (simultaneous double cancer and disease free period of allochronic double cancer is within 5 years. Basal cell cancer, squamous carcinoma, carcinoma in situ judged to be cured by local treatment, and lesion correspond to intramucosal carcinoma are not included in active double cancer.) 6) Patients who are judged to have difficulty in study participation by complication with mental disease or mental manifestation. 7) Patients with HBs antigen positive (cf. patients with HBs antibody and HBc antibody positive are not excluded, but patients who are detected HBV-DNA are excluded.) 8) Patients with HIV antibody positive. 9) Patients with autologous and allogeneic hematopoietic stem cell transplantation 10) Patients with comorbidity of interstitial pneumonia, radiation pneumonia and pulmonary fibrosis checked by a chest CT (within 3 months before registration). 11) Patients with infiltration to CNS. 12) Patients who had received bendamustine or judged to be inadequate of bendamustine administration 13) Patients with severe drug hypersensitivity. 14) Any other patients who are regarded as unsuitable for study enrollment by the investigators

研究者

发起方
Cooperative study between the West Japan Hematology Study Group and Clinical Research Support Center Kyushu

相似试验